GENETIC RISK OF IBD: PREDICTORS OF LOSS OF RESPONSE AND NEED FOR ANTI-TNF THERAPY

被引：0
|
作者：
Ramprasad, Chethan
Estes, Derek
Damas, Oriana M.
Quintero, Maria A.
Martinez, Adriana
Abreu, Maria T.
McCauley, Jacob L.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)33339-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1842
引用
收藏
页码：S986 / S986
页数：1
相关论文
共 50 条
  • [1] Hypergammaglobulinemia, hypoalbuminemia, and elevated CRP levels are predictors of a secondary loss of response to anti-TNFα therapy in IBD
    Schoenefuss, F.
    Hoffmann, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S362 - S363
  • [2] Genetic and genomic predictors of anti-TNF response
    Prajapati, Rita
    Plant, Darren
    Barton, Anne
    [J]. PHARMACOGENOMICS, 2011, 12 (11) : 1571 - 1585
  • [3] Is There an Increased Risk of Lymphoma and Malignancies Under Anti-TNF Therapy in IBD?
    Lakatos, P. L.
    Miheller, P.
    [J]. CURRENT DRUG TARGETS, 2010, 11 (02) : 179 - 186
  • [4] Genetic Associations with Adverse Events from Anti-TNF Therapy in IBD Patients
    Lew, Daniel
    Yoon, Soon Man
    Yan, Xiaofei
    Robbins, Lori
    Haritunians, Talin
    Li, Dalin
    McGovern, Dermot
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S271 - S272
  • [5] IBD Antibodies to anti-TNF therapy-consequences for IBD management
    van Deen, Welmoed K.
    Hommes, Daniel W.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (08) : 446 - 448
  • [6] Antibodies to anti-TNF therapy—consequences for IBD management
    Welmoed K. van Deen
    Daniel W. Hommes
    [J]. Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 446 - 448
  • [7] Tryptophan as a biomarker for the course of IBD and anti-TNF α response
    Brandt, B.
    Nikolaus, S.
    Al-Massad, N.
    Bethge, J.
    Schuldt, D.
    Szymczak, S.
    Thieme, F.
    Waetzig, G. H.
    Krawczak, M.
    Junker, R.
    Rosenstiel, P.
    Schreiber, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S267 - S267
  • [8] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [9] Anti-TNF withdrawal in IBD
    Thomas, Hugh
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (12): : 1076 - 1076
  • [10] Anti-TNF and IBD: bibliography
    Roblin, X.
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 482 - 485
12345